{"schema_version":"1","generated_at":"2026-11-08T17:30:08.792Z","data_as_of":null,"url":"https://www.findmykol.com/kol/charlene-fares","json_url":"https://www.findmykol.com/kol/charlene-fares/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"charlene-fares","name":"Charlene Fares","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Allina Health","institution_url":"https://www.findmykol.com/institution/allina-health","city":"Saint Paul","state":"MN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1952795841","orcid":"0000-0002-7003-5917","openalex":"A5047786994"},"summary":"Charlene Fares is an Oncology physician affiliated with Allina Health. OpenAlex indexes 18 publications with 784 citations (h-index 6).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":18,"cited_by_count":784,"h_index":6,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":18,"shown":3,"withheld":15,"rows":[{"payer":"Merck & Co.","program_year":2025,"amount_usd":1010319.26,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952795841"},{"payer":"AstraZeneca","program_year":2025,"amount_usd":161112.37,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952795841"},{"payer":"Amgen","program_year":2025,"amount_usd":130233.05,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952795841"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1952795841","source":"payments"},"publications":{"total":18,"shown":5,"withheld":13,"matched_by":"OpenAlex author record","recent":[{"title":"Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors","year":2026,"journal":"Frontiers in Oncology","source_url":"https://doi.org/10.3389/fonc.2026.1786385","status":"verified"},{"title":"Abstract 4340: HLA-B44 motif neoepitope is associated with a favorable tumor immune microenvironment and predicts ICB response in NSCLC","year":2023,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2023-4340","status":"verified"},{"title":"146 HLA-B44 motif neoepitope is associated with an anti-tumor immune microenvironment and predicts response to immune checkpoint blockade in non-small cell lung cancer","year":2023,"journal":"Regular and Young Investigator Award Abstracts","source_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0146","status":"verified"},{"title":"Homologous Recombination Deficiency and Molecular Subtype are Associated with Immunogenicity in Ovarian Cancer","year":2022,"journal":"Biomarkers in Medicine","source_url":"https://doi.org/10.2217/bmm-2022-0044","status":"verified"},{"title":"Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC","year":2021,"journal":"Lung Cancer","source_url":"https://doi.org/10.1016/j.lungcan.2021.08.009","status":"verified"}],"source":"works"},"contact":{"address_1":"310 SMITH AVE N STE 300","city":"Saint Paul","state":"MN","zip":"551022383","phone":"651-241-5111","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1952795841","source":"identity"},"similar":[{"name":"Michael Miedema","slug":"michael-miedema","institution":"Allina Health","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/michael-miedema","json_url":"https://www.findmykol.com/kol/michael-miedema/profile.json"},{"name":"Joleen Hubbard","slug":"joleen-hubbard","institution":"Allina Health","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/joleen-hubbard","json_url":"https://www.findmykol.com/kol/joleen-hubbard/profile.json"},{"name":"Craig Strauss","slug":"craig-strauss","institution":"Allina Health","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/craig-strauss","json_url":"https://www.findmykol.com/kol/craig-strauss/profile.json"},{"name":"Amy Krie","slug":"amy-krie","institution":"Allina Health","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/amy-krie","json_url":"https://www.findmykol.com/kol/amy-krie/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":15,"publications":13}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-08-02","provider_certified":"2022-08-02","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}